Immune Response To Intranasal Influenza Vaccination

NCT01866540 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Tonsillitis, Hypertrophy

Interventions

DRUG: FLUENZ

Sponsor

University of Bergen

Collaborators

[object Object]